Effects of Coffee on Hepatic Steatosis Induced by a High Fructose Diet
NCT00827450 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13
Last updated 2012-02-24
Summary
This study will assess
* whether coffee consumption protects against fructose-induced hepatic steatosis in healthy humans
* whether the protective effect of coffee is dependent on it's antioxidant composition
Conditions
- Hepatic Steatosis
Interventions
- DIETARY_SUPPLEMENT
-
Ctl
Control, isocaloric diet; no coffee
- DIETARY_SUPPLEMENT
-
High fructose diet; no coffee
Hypercaloric, high fructose diet; no coffee
- DIETARY_SUPPLEMENT
-
fully torrefied, caffeine-free coffee
Hypercaloric, high fructose diet + coffee
- DIETARY_SUPPLEMENT
-
partially torrefied, caffeine-free coffee
Hypercaloric, high fructose diet + coffee
- DIETARY_SUPPLEMENT
-
Partially torrefied, caffeinated coffee
Hypercaloric, high fructose diet + coffee
Sponsors & Collaborators
-
Nestlé Research Center, Vers-chez-les-blanc, Switzerland
collaborator UNKNOWN -
University of Lausanne
lead OTHER
Principal Investigators
-
Luc Tappy, MD · Department of Physiology, University of Lausanne, Switzerland
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- QUADRUPLE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 30 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2009-02-28
- Primary Completion
- 2010-12-31
- Completion
- 2011-03-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Impact of Fructose on Metabolism, Energy Homeostasis and Magnetic Resonance Biomarkers in Nonalcoholic Fatty Liver Disease
NCT01930123 ·Status: TERMINATED ·Phase: PHASE2
-
Prevalence of NAFLD and Correlation With Its Main Risk Factors Among Egyptian
NCT04081571 ·Status: UNKNOWN
-
Application of the Stem Cell Therapy in the End Stage Liver Disease and Assessment Its Consequences in the Quality of Live Style as Well as Development of HCC.
NCT01729221 ·Status: UNKNOWN
-
Identification of Biomarkers Related to Liver Fibrosis as New Therapeutic Targets
NCT03979417 ·Status: COMPLETED
-
Effectiveness of Endoscopic Sleeve Gastroplasty in Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
NCT05507151 ·Status: ACTIVE_NOT_RECRUITING
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives
NCT07303140 ·Status: RECRUITING
-
Quantifying Steatosis in Liver Transplant Donors
NCT02579408 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With Heterozygous Familial Hypercholesterolemia
NCT06634160 ·Status: RECRUITING
-
Association of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus
NCT01997424 ·Status: COMPLETED ·Phase: NA
-
Hepatic Steatosis After Cholecystectomy
NCT02493153 ·Status: UNKNOWN
-
Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD
NCT02031913 ·Status: COMPLETED
-
Determination of Insulin-stimulated Hepatic Glucose Uptake by PET-CT Measurements
NCT04938544 ·Status: UNKNOWN
-
Transient Elastography in Hepatectomy for Hepatocellular Carcinoma
NCT01441453 ·Status: UNKNOWN ·Phase: NA
-
Metabolic Surgery for Steato-Hepatitis
NCT04282005 ·Status: UNKNOWN ·Phase: NA
-
Use of N-Acetylcysteine During Liver Procurement
NCT01394497 ·Status: COMPLETED ·Phase: PHASE2
-
Mitochondrial Metabolism and Hepatic Complications of Obesity
NCT03302481 ·Status: WITHDRAWN ·Phase: NA
-
Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver Disease
NCT02860884 ·Status: COMPLETED
-
Change of Glucose Metabolism and Fibrosis Markers in Patients With Hepatitis C Under Treatment With Antiviral Agents
NCT03908294 ·Status: COMPLETED
-
Non Alcoholic Steatohepatitis in Relation to Visceral and Subcutaneous Fat
NCT04240145 ·Status: UNKNOWN
-
Estimation of Steatosis on Liver Transplants by Intraoperative Spectrometry
NCT05106322 ·Status: RECRUITING
-
Potential Association of a Common L-FABP Polymorphism With Lipid-induced Hepatic Insulin Resistance
NCT00277342 ·Status: COMPLETED ·Phase: NA
-
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
NCT03635541 ·Status: UNKNOWN
-
Controlled Attenuation Parameter (CAP) in Liver Allografts
NCT02798861 ·Status: COMPLETED
-
Subclinical Diabetes Confirmed by 75gm-OGTT Influence on the Prognosis of Decompensated Cirrhosis
NCT04828512 ·Status: UNKNOWN